Data Asset Potential sales opportunity around expanding data integration and analytics services to enhance Akrivia Health's neuropsychiatric and neurodegenerative dataset, leveraging their interest in high‑quality real-world evidence and patient stratification.

AI Enablement Cross-sell advanced NLP and AI solutions to further improve extraction of phenotypic signals from clinical notes, enabling faster insight generation for researchers, pharma, and healthcare providers.

Clinical Trials Position offerings for trial optimization and real-world evidence generation to support more efficient patient recruitment, outcome tracking, and precision care strategies sought by pharma partners.

Partnership Readiness Leverage NHS and Oxford University origins to propose collaboration models, data-sharing frameworks, and co-development opportunities with academic institutions and biotech firms.

Scale Opportunity Target mid‑sized health tech and data analytics vendors as potential acquirers or strategic partners in the AI health data space, aligning with Akrivia Health’s funding profile and growth trajectory.